Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.

The resultant precoders only need to be updated once per block, and while not necessarily constant over all the symbol slots, we refer to the technique as block-level slot-variant IE precoding.